What is the significance of monoclonal gammopathy of undetermined significance?
Catherine Atkin, Alex Richter and Elizabeth Sapey
DOI: https://doi.org/10.7861/clinmedicine.18-5-391
Clin Med October 2018 Catherine Atkin
AInstitute of Inflammation and Ageing, University of Birmingham, Birmingham, UK
Roles: clinical research fellow
Alex Richter
BInstitute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK
Roles: senior lecturer and consultant in clinical immunology
Elizabeth Sapey
CInstitute of Inflammation and Ageing, University of Birmingham, Birmingham, UK
Roles: reader and consultant in respiratory medicine

Article Information
vol. 18 no. 5 391-396
PubMed:
Published By:
Print ISSN:
Online ISSN:
History:
- Published online October 4, 2018.
Copyright & Usage:
© Royal College of Physicians 2018. All rights reserved.
Author Information
- Catherine Atkin, clinical research fellowA,*,
- Alex Richter, senior lecturer and consultant in clinical immunologyB,* and
- Elizabeth Sapey, reader and consultant in respiratory medicineC,*⇑
- AInstitute of Inflammation and Ageing, University of Birmingham, Birmingham, UK
- BInstitute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK
- CInstitute of Inflammation and Ageing, University of Birmingham, Birmingham, UK
- Address for correspondence: Dr Elizabeth Sapey, Institute of Inflammation and Ageing, Queen Elizabeth Hospital, Mindelsohn Way, Edgbaston, Birmingham B15 2GW, UK. Email: e.sapey{at}bham.ac.uk
Article usage
Cited By...
Article Tools
What is the significance of monoclonal gammopathy of undetermined significance?
Catherine Atkin, Alex Richter, Elizabeth Sapey
Clinical Medicine Oct 2018, 18 (5) 391-396; DOI: 10.7861/clinmedicine.18-5-391
Citation Manager Formats
Jump to section
Related Articles
- No related articles found.